Resumo

RAMIREZ, Juan; MEJIA, Sergio  e  QUIROGA, Alicia. Neumonitis por docetaxel, discusión de un caso. rev.colomb.cancerol. [online]. 2019, vol.23, n.2, pp.65-67. ISSN 0123-9015.  https://doi.org/10.35509/01239015.67.

Interstitial pneumonitis due to docetaxel is an infrequent event but with a high mortality potential; it can be potentially reversible with the use of systemic steroids and is considered important in the differential diagnosis of the patient undergoing chemotherapy with respiratory symptoms. We present a case of fatal pneumonitis due to docetaxel in a patient with advanced prostate carcinoma. An 80-year-old patient with a history of prostate cancer of15 years of evolution, with disease progression in bones and lymph nodes, in whom treatment with Docetaxel was started, after the application of the third cycle, he presented with dyspnea on exertion, fever, dry cough and general deterioration. A diagnosis of pneumonitis due to docetaxel was made, discarding other entities. Interstitial pneumonitis due to docetaxel is a rare entity. The pillars of the treatment are the suspension of the medication, the ventilatory support and the use of systemic glucocorticoids.

Palavras-chave : Consolidation Chemo therapy; Interstitial Lung Diseases; Prostate Neoplasms.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )